Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.

Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.

MGP Ingredients, Inc. (NASDAQ:MGPI) is one of the best undervalued defensive stocks to buy according to analysts. Analyst ...

Diamedica Therapeutics ( ($DMAC) ) just unveiled an announcement. On August 12, 2025, DiaMedica Therapeutics Inc. entered into a Sales Agreement ...

Morgan Stanley said Rivian shows promise in AI-enabled autonomy but expressed reservations about the steering-wheel-equipped ...

SPX Technologies, Inc. (NYSE:SPXC) (“SPX”) announced today the pricing of an underwritten public offering of 2,659,575 shares ...

The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...

With economic headwinds continuing to weigh on travel demand, CoStar and Tourism Economics again revised their 2025 forecast.

Air Canada said on Tuesday it has asked for federal government intervention in contract talks with its flight attendants ...

Tilray Inc.'s stock extended its double-digit percentage gains to a second session in Tuesday-morning trading, a day after ...

TD Cowen lowered the firm’s price target on Humacyte (HUMA) to $3.50 from $5 and keeps a Buy rating on the shares. The firm said the Symvess ...

Mondelez’s second quarter results were met with a negative market reaction, despite revenue and non-GAAP profit both ...